Search clinical trials for: Membranoproliferative Glomerulonephritis
Total 637 results
-
UK Kidney AssociationRecruitingVasculitis | AL Amyloidosis | Tuberous Sclerosis | Fabry Disease | Cystinuria | Focal Segmental Glomerulosclerosis | IgA Nephropathy | Bartter Syndrome | Pure Red Cell Aplasia | Membranous Nephropathy | Atypical Hemolytic Uremic Syndrome | Autosomal Dominant Polycystic Kidney Disease | Cystinosis | Nephronophthisis | BK Nephropathy and other conditionsUnited Kingdom
-
Mario Negri Institute for Pharmacological ResearchRecruitingDeveloping a Pipeline to Employ RNA-Seq as a Complementary Diagnostic Tool in Rare Diseases (ANTHEM)Healthy | Autosomal Dominant Polycystic Kidney | Atypical Hemolytic Uremic Syndrome | Membranoproliferative GlomerulonephritisItaly
-
Mario Negri Institute for Pharmacological ResearchRecruitingHealthy | Hemolytic-Uremic Syndrome | Membranoproliferative GlomerulonephritisItaly
-
Novartis PharmaceuticalsRecruitingIC-MPGNFrance, Germany, Spain, Switzerland, Japan, United States, Canada, India, United Kingdom, Israel, Brazil, Turkey, Italy, Vietnam, Argentina, Czechia, Poland
-
Region SkaneRecruitingC3 Glomerulopathy | C3 Glomerulonephritis | Dense Deposit Disease | Membranoproliferative Glomerulonephritis | Complement AbnormalitySweden
-
Leiden University Medical CenterGlaxoSmithKline; Dutch Kidney FoundationRecruitingLupus Erythematosus, SystemicNetherlands
-
Apellis Pharmaceuticals, Inc.AvailableC3G | IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Complement 3 Glomerulopathy | Complement 3 Glomerulopathy (C3G) | Complement 3 Glomerulonephritis | Dense Deposit Disease | DDD | Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis (MPGN) | Immune Complex Membranoproliferative...United States
-
ChemoCentryxMedpace, Inc.CompletedC3 Glomerulopathy (C3G)United States, Spain, France, Netherlands, Belgium, Canada, Denmark, Germany, Ireland, Italy, United Kingdom
-
Apellis Pharmaceuticals, Inc.Active, not recruitingC3G | IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Complement 3 Glomerulopathy | Complement 3 Glomerulopathy (C3G) | Complement 3 Glomerulonephritis | Dense Deposit Disease | DDD | Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis (MPGN) | Immune Complex Membranoproliferative...United States, Spain, France, Germany, United Kingdom, Netherlands, Brazil, Israel, Japan, Australia, Austria, Italy, Switzerland, Korea, Republic of, Czechia, Belgium, Argentina, Canada, Poland
-
Apellis Pharmaceuticals, Inc.Active, not recruitingC3G | IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Complement 3 Glomerulopathy | Complement 3 Glomerulopathy (C3G) | Complement 3 Glomerulonephritis | Dense Deposit Disease | DDD | Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis (MPGN) | Immune Complex Membranoproliferative...United States, Australia, Brazil, Czechia, France, Italy, Korea, Republic of, Netherlands, Spain, Switzerland, United Kingdom
-
Apellis Pharmaceuticals, Inc.Active, not recruitingRenal Transplant | C3G | IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Complement 3 Glomerulopathy | Complement 3 Glomerulopathy (C3G) | Complement 3 Glomerulonephritis | Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis (MPGN) | Immune Complex Membranoproliferative... and other conditionsUnited States, Australia, Austria, United Kingdom, Brazil, Argentina, France, Italy, Netherlands, Spain, Switzerland
-
AlexionTerminatedIC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Dense Deposit Disease | Immune Complex Membranoproliferative GlomerulonephritisUnited States, Australia, Belgium, Italy, Netherlands
-
AlexionCompletedProteinuriaKorea, Republic of
-
Apellis Pharmaceuticals, Inc.Active, not recruitingLupus Nephritis | IgA Nephropathy | Membranous Nephropathy | C3 Glomerulonephritis | Dense Deposit DiseaseUnited States
-
Alexion PharmaceuticalsCompletedC3 Glomerulopathy | C3 Glomerulonephritis | Dense Deposit DiseaseUnited Kingdom, United States
-
Fernando FervenzaCompleted
-
Mario Negri Institute for Pharmacological ResearchAlexion PharmaceuticalsCompletedIC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Dense Deposit Disease | Immune Complex Membranoproliferative GlomerulonephritisItaly
-
Alexion PharmaceuticalsAchillion, a wholly owned subsidiary of AlexionCompletedC3 Glomerulopathy | C3 Glomerulonephritis | Dense Deposit Disease | Immune Complex Mediated Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis Types I, II, and IIINetherlands, Australia, Belgium
-
Omeros CorporationUnknownLupus Nephritis | IgAN | C3 Glomerulopathy | MNUnited States, Hong Kong
-
Children's Hospital of PhiladelphiaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); American... and other collaboratorsCompleted
-
Columbia UniversityAlexion PharmaceuticalsCompletedDense Deposit Disease | Membranoproliferative GlomerulonephritisUnited States
-
Mario Negri Institute for Pharmacological ResearchAlexion Pharma Italy s.r.l.Completed
-
Assiut UniversityUnknownMembranoproliferative Glomerulonephritis
-
University of IowaWithdrawn
-
University of IowaWithdrawn
-
Celldex TherapeuticsTerminatedC3 Glomerulonephritis | Dense Deposit Disease | Membranoproliferative Glomerulonephritis Type IIUnited States
-
Mayo ClinicCompletedGlomerulonephritis, MembranoproliferativeUnited States
-
National Institute of Arthritis and Musculoskeletal...CompletedLupus Nephritis | Glomerulonephritis, MembranoproliferativeUnited States
-
NovelMed TherapeuticsNot yet recruiting
-
Johns Hopkins UniversityJanssen Scientific Affairs, LLCRecruitingLupus Erythematosus, Systemic | Lupus Nephritis | SLE | Lupus | SLE (Systemic Lupus) | SLE Nephritis | SLE; Glomerulonephritis (Etiology)United States
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingFocal Segmental Glomerulosclerosis | Nephrotic Syndrome | APOL1 Associated Kidney DiseaseFrance
-
Atara BiotherapeuticsNot yet recruitingSystemic Lupus Erythematosus | Lupus Nephritis
-
Q32 Bio Inc.Not yet recruitingIgA Nephropathy | Lupus Nephritis (LN) | C3 (Complement Component 3) Glomerulopathy
-
Qilu Pharmaceutical Co., Ltd.Recruiting
-
Peking University First HospitalNot yet recruitingObstructive Sleep Apnea | IgA Nephropathy
-
TakedaNot yet recruitingRefractory Lupus NephritisUnited States
-
Adicet TherapeuticsNot yet recruitingAutoimmune Diseases | Lupus Nephritis
-
Centre Hospitalier Universitaire de Saint EtienneMinistry of Health, FranceNot yet recruiting
-
Essen BiotechNot yet recruitingAutoimmune Diseases | Systemic Lupus Erythematosus | Systemic Sclerosis | Lupus Nephritis | Microscopic Polyangiitis | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | Sjogren's Syndrome | Idiopathic Inflammatory Myopathies | Granulomatous PolyangiitisChina
-
Kyverna TherapeuticsRecruitingLupus Nephritis | Lupus Nephritis - WHO Class IV | Lupus Nephritis - WHO Class IIIGermany
-
Centre Hospitalier Universitaire de NiceNot yet recruiting
-
Alexandria UniversityNot yet recruiting
-
Iain BressendorffDitte Hansen MD PhD; Casper Rydahl MD; Anders Nordholm MD PhD; Eva Gravesen MD PhDNot yet recruitingNephrotic Syndrome | Minimal Change Disease | Membranous Nephropathy | Primary Focal Segmental Glomerulosclerosis
-
Mayo ClinicRecruitingFibrillary GlomerulonephritisUnited States
-
Alexion Pharmaceuticals, Inc.RecruitingImmunoglobulin A Nephropathy | IgANSpain, United Kingdom, United States, Italy, Korea, Republic of, Belgium, Germany, Colombia, Japan, China, France, Saudi Arabia, Thailand, Australia, Canada, Brazil, Malaysia, Poland, Taiwan, Austria, Greece, Israel, Netherlands, Arge... and more
-
Assiut UniversityNot yet recruiting
-
Nanjing University School of MedicineRecruitingLupus Nephritis | ANCA-associated Vasculitis | Membranous Nephropathy - PLA2R Induced | IgG4-Related DiseasesChina
-
Lingli DongShenzhen Pregene Biopharma Co., Ltd.RecruitingLupus Nephritis | ANCA Associated VasculitisChina
-
Artiva Biotherapeutics, Inc.RecruitingLupus Nephritis - WHO Class IV | Lupus Nephritis - WHO Class IIIUnited States